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EditorialThe Future of Neuron and the Challenges
for Biomedical Research in Neuroscience
Almost 7 years ago I was accorded the opportunity of I urge the members of the entire neuroscience commu-
nity to wish Emilie well in her efforts to take Neuron tobeing Neuron’s first full-time Editor when the journal
moved from the University of California, San Francisco, greater heights. In doing so, please continue to send
your best research articles, ideas for commentaries, orto Cell Press in Cambridge, Massachusetts. In the able
hands of Zach Hall, Lou Reichardt, Jim Hudspeth, Lilly other contributions.
In this vein, I will recount a story to help shatter aJan, and Roger Nicoll, Neuron quickly rose from a fledgling
journal in 1988 to become the leading forum for studies widely held misconception of the principal role of a Neu-
ron editor. During a visit with French scientists in Paris,in developmental, cellular, and molecular neurobiology.
No less impressive was the breadth and depth of the one of them said that “Neuron is like a chic Parisian
night club, and you are the tough bouncer.” AlthoughNeuron full-length reviews, commissioned and edited
by Eric Kandel and Tom Jessell. flattered by the analogy, I quickly spoke up to correct
him. I stated that our role at Neuron was to give authorsDue to the desire to understand the neural systems
involved in normative brain function and their roles in guidance on what elements make a study appropriate
for Neuron and to return quickly those manuscripts thatthe pathogenesis of neuropsychiatric diseases, I set out
to broaden the scope of Neuron to include all areas of do not meet these criteria. We strive to make decisions
on manuscripts based on their scientific merits, throughneuroscience. Part of this expansion involved focusing
on systems neuroscience. When Su Koester joined me an understanding of their content and the critiques made
by the referees. Our most rewarding duty is to ensureas Senior Editor, we were able to provide more focused
commentaries in the form of minireviews, which comple- that paradigm-shifting studies, deemed promising but
in need of additional experimental evidence, receive themented the full-length reviews that Eric Kandel and Tom
Jessell continued to provide. Also, we introduced neuro- appropriate criticisms to produce the exceptional works
that appear in Neuron. Emilie will continue this strongtechnique papers for cutting-edge methodological stud-
ies. By the time that Adina Roskies and Emilie Marcus commitment to fairness and scientific excellence.
How can Neuron contribute to some of the greatestjoined us at Neuron, we were well on the way to becom-
ing a unique forum for the entire community of neurosci- challenges faced by neuroscience and our society as a
whole? Neuroscience will almost certainly be multidisci-entists, and systems neuroscience papers began to be
featured on Neuron covers at regular intervals. Last year, plinary in the 21st century. By publishing the major con-
ceptual advances in all areas of neuroscience, NeuronNeuron made a commitment to the publication of impor-
tant translational research. These clinical and case stud- hopes to promote and foster the kinds of cross-disciplin-
ary dialogues that will make the new generation of read-ies have already contributed important insights into hu-
man narcolepsy, autoimmune diseases of the nervous ers equally facile in systems and molecular-genetic
approaches. As the tools of genetics and functional ge-system, and schizophrenia.
During my tenure at Neuron, I have been fortunate nomics are added to the repertoire at the disposal of
neuroscientists, we need to understand the basis ofto work with a steady stream of wonderful colleagues,
including most recently Emilie Marcus, Kenny Blum, neuronal dysfunction with the goal of devising effective
treatments not only for the neurodegenerative diseases,Katja Brose, and Anu Rao. If any one element makes
Neuron the journal it is, it is our editors, who take the time but also for those disorders that carry the archaic term
“mental illness.” If the goals for neurology and psychia-to review carefully each manuscript and the comments
from referees. For better or worse, Neuron editors are try in the 21st century are to establish a more concrete
set of diagnoses, deliver more effective treatments withnot trained to simply moderate the dialogue between
authors and reviewers, but also to weigh in at every fewer side effects, and intervene earlier to arrest the
course of the debilitating neuropsychiatric diseases, westage with informed and thoughtful scientific evalua-
tions. I have cherished working with Eric Kandel and need to understand the hallmarks of these diseases
across multiple scales, temporal and spatial, of nervousTom Jessell, who have seen editors come and go while
keeping their commitment to Neuron. Also, I have en- system function. Studies that combine functional im-
aging of affected individuals and their nonaffected sib-joyed working with the members of the Neuron editorial
board and other referees, who have contributed enor- lings with appropriate cognitive/behavioral tests and
others that characterize nonhuman primate or the sim-mous amounts of work on behalf of the journal in addi-
tion to some of their best research manuscripts. Last pler rodent models of these diseases will lay the founda-
tions for clinical studies that will take promising scientificbut not least, I need to acknowledge the countless au-
thors who have entrusted their best efforts to us, making work from the bench to the bedside. By working with
researchers in basic and clinical neuroscience, the edi-Neuron an outstanding journal.
With the March issue, I will be stepping down as Editor tors of Neuron will continue to play an important role,
more than that of a gatekeeper or journalist and closerof Neuron to join the Center for Learning and Memory
at the Massachusetts Institute of Technology. Dr. Emilie to that of sage counsels striving to discern the larger
picture in the realm of integrative biology.Marcus, who has served as Deputy Editor of Cell and
Neuron, will become the next Editor of Neuron. She Why should we be so interested in the neurobiology
of disease? Besides the responsibility to society, under-possesses a rare combination of interpersonal skills, a
keen intellect, broad vision, and a fine sense of humor. standing the pathogenesis of these diseases comple-
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ments more basic approaches to illuminate brain func-
tion. We need to understand how the human brain
develops and correlate the cognitive stages of develop-
ment and aging with structural/functional changes in
different brain systems. For example, molecular and cel-
lular processes involved in neuronal differentiation, mi-
gration, and brain development appear to contribute to
the demise of neuronal systems in neurodegenerative dis-
eases. We need to elucidate the genetic, epigenetic, and
environmental components that come together to pro-
duce the genetically complex neuropsychiatric dis-
eases. We need insights into the pathophysiological pro-
cesses that often produce common symptoms and
impair the circuits that make up the human cognitive
and motivational systems. We have to understand how
present day pharmacological treatments and cognitive-
behavioral therapy cause symptomatic improvements
and whether they slow the progression of disease. We
need to develop objective criteria, qualitative and quan-
titative, to assess disease progression and treatment
efficacy. This knowledge may allow us to prevent or
attenuate the course of these diseases, taking advan-
tage of pharmacogenetics to deliver treatments that
take into account the genetic makeup and disease risk
of diverse individuals. In the process of this inquiry,
we stand to learn a great deal about normative brain
function. Although I have focused on understanding dis-
ease mechanisms, the confluence of systems and mo-
lecular-genetic approaches will provide us with funda-
mental insights into sensory, motor, and higher cognitive
processes.
Should Neuron be involved in shaping public policy
as well as education? As textbooks and other reference
materials move online, journals will have links to these
sources, and education of the more general reader will
become one of their mandates. Neuron can shape public
policy by providing a forum for discussion of important
issues and by helping set guidelines for the biomedical
research community. I believe that we need to be guided
by strong ethical criteria in our research employing hu-
mans and other mammals. In devising the genetic tests
to be used in prenatal screening for the genetically com-
plex neuropsychiatric disorders, in targeting stem cells
to repair/replace dysfunctional brain systems, and,
eventually, in the application of genetic engineering to
repair defective genes, we need guidelines that balance
science, medicine, and ethics. Equally important, we
need to revise our medical and house staff curriculum
to build a psychiatry that stands together with neurology
and is grounded in systems and behavioral neurosci-
ence. Basic research into normative brain function and
dysfunction at several levels will provide the unifying
principles and tools necessary to achieve these goals.
We hope that Neuron will continue to serve as a catalyst
and intellectual forum for the basic and clinical neurosci-
ence community to achieve these important goals. Bonne
chance a` Emilie et tous mes amis a` Neuron!
Gregory Gasic
February 2001
